Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Viatris
VTRS
$18.5B
| $11.4M | 0.02% |
1,143,597
-2,019,550
| -64% | -$19.3M |
|
|
AVDL
952
DELISTED
Avadel Pharmaceuticals
AVDL
| $11.4M | 0.02% |
692,106
-127,648
| -16% | -$1.66M |
|
953
Performance Food Group
PFGC
$16.9B
| $11.4M | 0.02% |
188,707
-339,800
| -64% | -$20M |
|
954
Accuray
ARAY
$33.4M
| $11.4M | 0.02% |
2,933,784
+28,500
| +1% | +$98.8K |
|
955
Americold
COLD
$4.17B
| $11.3M | 0.02% |
350,762
-373,938
| -52% | -$11.1M |
|
|
HTB
956
HomeTrust Bancshares
HTB
$831M
| $11.3M | 0.02% |
542,315
-3,200
| -0.6% | -$68K |
|
957
Coursera
COUR
$1.48B
| $11.3M | 0.02% |
869,900
-172,500
| -17% | -$2.06M |
|
958
Champion Homes
SKY
$5.1B
| $11.3M | 0.02% |
172,200
-220,800
| -56% | -$15M |
|
959
Canadian Imperial Bank of Commerce
CM
$110B
| $11.3M | 0.02% |
263,928
-365,100
| -58% | -$15.4M |
|
960
Valmont Industries
VMI
$9.52B
| $11.3M | 0.02% |
38,700
+35,600
| +1,148% | +$10.3M |
|
961
Progyny
PGNY
$1.95B
| $11.3M | 0.02% |
286,200
-195,800
| -41% | -$7.07M |
|
962
Globe Life
GL
$13.8B
| $11.3M | 0.02% |
+102,700
| New | +$11M |
|
963
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.6B
| $11.3M | 0.02% |
232,700
+143,900
| +162% | +$6.65M |
|
964
WEX
WEX
$6.48B
| $11.3M | 0.02% |
+61,800
| New | +$10.9M |
|
965
Safe Bulkers
SB
$760M
| $11.2M | 0.02% |
3,448,886
+312,331
| +10% | +$1.1M |
|
966
Gulfport Energy Corp
GPOR
$3B
| $11.2M | 0.02% |
106,900
-11,200
| -9% | -$1.04M |
|
967
Civeo
CVEO
$345M
| $11.2M | 0.02% |
574,148
-40,100
| -7% | -$809K |
|
|
LPRO
968
DELISTED
Open Lending Corp
LPRO
| $11.2M | 0.02% |
1,062,525
+210,300
| +25% | +$1.86M |
|
969
WSFS Financial
WSFS
$4.15B
| $11.1M | 0.02% |
295,326
+59,671
| +25% | +$2.12M |
|
970
Federal Agricultural Mortgage
AGM
$2.58B
| $11.1M | 0.02% |
77,200
-700
| -0.9% | -$96K |
|
971
Climb Global Solutions
CLMB
$527M
| $11.1M | 0.02% |
923,836
+118,720
| +15% | +$1.45M |
|
|
SILK
972
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $11M | 0.02% |
339,200
-154,400
| -31% | -$5.64M |
|
973
RCM Technologies
RCMT
$202M
| $11M | 0.02% |
598,073
-53,210
| -8% | -$778K |
|
974
Badger Meter
BMI
$3.91B
| $11M | 0.02% |
74,400
-49,500
| -40% | -$6.81M |
|
975
Arlo Technologies
ARLO
$1.5B
| $10.9M | 0.02% |
1,001,020
-356,972
| -26% | -$2.9M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.